Home › Hereditary Sensory and Autonomic Neuropathies
Pag-aaral pangklinika para sa Hereditary Sensory and Autonomic Neuropathies na nagre-recruit sa U.S.
21 pag-aaral para sa Hereditary Sensory and Autonomic Neuropathies ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- San Antonio, TX7 pag-aaral
- Arlington, VA7 pag-aaral
- Boston, MA6 pag-aaral
- Nashville, TN6 pag-aaral
- New York City, NY6 pag-aaral
- Philadelphia, PA5 pag-aaral
- Houston, TX5 pag-aaral
- Washington, DC4 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Portland, OR4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- Aurora, CO3 pag-aaral
- Los Angeles, CA3 pag-aaral
- San Francisco, CA3 pag-aaral
- Charlotte, NC3 pag-aaral
- Denver, CO3 pag-aaral
- Cincinnati, OH3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California9 pag-aaral
- Colorado7 pag-aaral
- District of Columbia3 pag-aaral
- Florida7 pag-aaral
- Maryland5 pag-aaral
- Massachusetts6 pag-aaral
- Michigan5 pag-aaral
- Minnesota3 pag-aaral
- Missouri3 pag-aaral
- New York8 pag-aaral
- North Carolina5 pag-aaral
- Ohio6 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania9 pag-aaral
- Tennessee6 pag-aaral
- Texas11 pag-aaral
- Virginia7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT046451609-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06896188Study of ACR-2316 in Specific Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06667141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT02886247A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT01238250First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT05010031A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Abr 22, 2026 · NCT05683418Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 100 · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05868629A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Nagre-recruitPhase 1
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT07064122Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT06599619Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Dis 24, 2025 · NCT06463028The Natural History of Familial Dysautonomia
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Nob 10, 2025 · NCT03920774The Cancer of the Pancreas Screening-5 CAPS5)Study
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT02000089Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 29, 2025 · NCT01793168Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.